Outcomes after laparoscopic hepatectomy in the semi-prone position for hepatocellular carcinoma located in segment 6,7, or 8

Norifumi Harimoto, Tetsuo Ikeda, Kazuki Takeishi, Shinji Itoh, Yo Ichi Yamashita, Toru Ikegami, Tomoharu Yoshizumi, Hirofumi Kawanaka, Ken Shirabe, Yoshihiko Maehara

研究成果: Contribution to journalArticle

3 引用 (Scopus)

抜粋

Background: This retrospective study investigated outcomes after laparoscopic hepatectomy in the semi-prone position compared to open hepatectomy in the conventional supine position, for HCC (hepatocellular carcinoma) located in segment 6, 7, or 8. Patients and Methods: Patients were divided into two groups according to the surgical approach. The clinicopathological and surgical outcomes were analyzed. Results: There were no significant differences in patient-related or tumor-related factors between the two groups. The laparoscopic-hepatectomy group had significantly less blood loss, fewer postoperative complications, and a shorter hospital stay than the open-hepatectomy group. There were no in-hospital deaths. The postoperative change in the serum C-reactive protein was a significantly larger decrease in the group treated with laparoscopic hepatectomy than that in the open-hepatectomy group. Conclusion: Laparoscopic hepatectomy in the semi-prone position for HCC is safe and minimally invasive, and can reduce intraoperative bleeding, postoperative complications, and hospital stay compared to open hepatectomy.

元の言語英語
ページ(範囲)4167-4170
ページ数4
ジャーナルAnticancer research
35
発行部数7
出版物ステータス出版済み - 7 1 2015

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

フィンガープリント Outcomes after laparoscopic hepatectomy in the semi-prone position for hepatocellular carcinoma located in segment 6,7, or 8' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用

    Harimoto, N., Ikeda, T., Takeishi, K., Itoh, S., Yamashita, Y. I., Ikegami, T., Yoshizumi, T., Kawanaka, H., Shirabe, K., & Maehara, Y. (2015). Outcomes after laparoscopic hepatectomy in the semi-prone position for hepatocellular carcinoma located in segment 6,7, or 8. Anticancer research, 35(7), 4167-4170.